Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
Columbus Biotechnology (06990.HK): CSRC Issues Filing Notice for Company's Full Circulation of H Shares
Recommend 1 Positive 1 Negative 0 |
||||
|
||||
|
Columbus Biotechnology-B (06990.HK) announced that the company has received a filing notice dated March 26, 2026, from the China Securities Regulatory Commission (CSRC) regarding the implementation of full circulation of H shares. According to the filing notice, the company's filing with the CSRC for the full circulation of approximately 8.21 million domestic shares and unlisted foreign shares has been completed. As of the date of this announcement (March 27), the details of the implementation plan for the full circulation and conversion and listing of H shares have not yet been finalized. (hc/da) Auto-translated by third-party software This translation was auto-generated by third-party software. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
